Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI

被引:2
|
作者
Garcia-Gutierrez, Fernando [1 ]
Hernandez-Lorenzo, Laura [1 ]
Cabrera-Martin, Maria Nieves [2 ]
Matias-Guiu, Jordi A. [3 ]
Ayala, Jose L. [1 ]
机构
[1] Univ Complutense, Dept Comp Architecture & Automat, Madrid, Spain
[2] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Nucl Med, Madrid, Spain
[3] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Neurol, Madrid, Spain
关键词
Neurodegenerative diseases; Alzheimer disease; Neuroimaging; Positron-emission tomography; Artificial intelligence; Machine learning; Deep learning; Automated pattern recognition; ALZHEIMERS-DISEASE; DECLINE; CONNECTIVITY; CORTEX; PET;
D O I
10.1016/j.neuroimage.2024.120695
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The prediction of Alzheimer's disease (AD) progression from its early stages is a research priority. In this context, the use of Artificial Intelligence (AI) in AD has experienced a notable surge in recent years. However, existing investigations predominantly concentrate on distinguishing clinical phenotypes through cross-sectional approaches. This study aims to investigate the potential of modeling additional dimensions of the disease, such as variations in brain metabolism assessed via [ 18 F]-fluorodeoxyglucose positron emission tomography (FDG-PET), and utilize this information to identify patients with mild cognitive impairment (MCI) who will progress to dementia (pMCI). Methods: We analyzed data from 1,617 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) who had undergone at least one FDG-PET scan. We identified the brain regions with the most significant hypometabolism in AD and used Deep Learning (DL) models to predict future changes in brain metabolism. The best-performing model was then adapted under a multi-task learning framework to identify pMCI individuals. Finally, this model underwent further analysis using eXplainable AI (XAI) techniques. Results: Our results confirm a strong association between hypometabolism, disease progression, and cognitive decline. Furthermore, we demonstrated that integrating data on changes in brain metabolism during training enhanced the models' ability to detect pMCI individuals (sensitivity=88.4%, specificity=86.9%). Lastly, the application of XAI techniques enabled us to delve into the brain regions with the most significant impact on model predictions, highlighting the importance of the hippocampus, cingulate cortex, and some subcortical structures. Conclusion: This study introduces a novel dimension to predictive modeling in AD, emphasizing the importance of projecting variations in brain metabolism under a multi-task learning paradigm.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Prediction of Cytochrome P450 Substrates Using the Explainable Multitask Deep Learning Models
    Fang, Jiaojiao
    Tang, Yan
    Gong, Changda
    Huang, Zejun
    Feng, Yanjun
    Liu, Guixia
    Tang, Yun
    Li, Weihua
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (09) : 1535 - 1548
  • [42] Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease
    Persson, Karin
    Barca, Maria Lage
    Eldholm, Rannveig Sakshaug
    Cavallin, Lena
    Benth, Jurate Saltyte
    Selbaek, Geir
    Braekhus, Anne
    Saltvedt, Ingvild
    Engedal, Knut
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2017, 44 (1-2) : 12 - 24
  • [43] Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance
    Jester, Dylan J.
    Vyhnalek, Martin
    Andel, Ross
    Markova, Hana
    Nikolai, Tomas
    Laczo, Jan
    Matuskova, Veronika
    Cechova, Katerina
    Sheardova, Katerina
    Hort, Jakub
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (04) : 1763 - 1774
  • [44] Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
    Ramusino, Matteo Cotta
    Massa, Federico
    Festari, Cristina
    Gandolfo, Federica
    Nicolosi, Valentina
    Orini, Stefania
    Nobili, Flavio
    Frisoni, Giovanni B.
    Morbelli, Silvia
    Garibotto, Valentina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (07) : 1876 - 1890
  • [45] Is brain SPECT a useful tool for detecting the rapid progression of mild cognitive impairment (MCI) to dementia?
    Gabryelewicz, T
    Pfeffer, A
    Luczywek, E
    Barczak, A
    Wasiak, B
    Czyzewski, K
    Barcikovska, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S286 - S286
  • [46] Age-Correction of Test Scores Reduces the Validity of Mild Cognitive Impairment in Predicting Progression to Dementia
    Hessler, Johannes
    Tucha, Oliver
    Foerstl, Hans
    Moesch, Edelgard
    Bickel, Horst
    PLOS ONE, 2014, 9 (08):
  • [47] Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification
    Korolev, Igor O.
    Symonds, Laura L.
    Bozoki, Andrea C.
    PLOS ONE, 2016, 11 (02):
  • [48] Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging
    Choi, Hongyoon
    Jin, Kyong Hwan
    BEHAVIOURAL BRAIN RESEARCH, 2018, 344 : 103 - 109
  • [49] Identification of Dementia & Mild Cognitive Impairment in Chinese Elderly Using Machine Learning
    Ying, Tong-Tong
    Zhuang, Li-Ying
    Xu, Shan-Hu
    Zhang, Shu-Feng
    Huang, Li-Jun
    Gao, Wei-Wei
    Liu, Lu
    Lai, Qi-Lun
    Lou, Yue
    Liu, Xiao-Li
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2024, 39
  • [50] Increased Basal Forebrain Metabolism in Mild Cognitive Impairment: An Evidence for Brain Reserve in Incipient Dementia
    Kim, Min-Jeong
    Lee, Kyoung-Min
    Son, Young-Don
    Jeon, Hyeon-Ae
    Kim, Young-Bo
    Cho, Zang-Hee
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (04) : 927 - 938